Ventricular Assist Devices (VAD)

This channel includes news and new technology innovations for Ventricular Assist Devices (VAD). VADs are a type of hemodynamic support device that helps increase blood flow in people who have ventricles that don't work properly.

The Abiomed Impella RP had higher than expected mortality in its post approval study, much higher than in its pre-market approval study. The vendor and the FDA believe this might be due to poor patient selection and implanting the device too late to aid the patient.

The Abiomed Impella RP had higher than expected mortality in its post-approval study, much higher than in its pre-market approval study. The vendor and the FDA believe this might be due to poor patient selection and implanting the device too late to aid the patient.

Feature | Hemodynamic Support Devices | February 05, 2019 | Dave Fornell, Editor

The U.S. Food and Drug Administration (FDA) sent a letter to cardiologists this week to explain its evaluation of...

Sponsored Content | Videos | January 10, 2019

...

Transplanting Pig Hearts Into Humans One Step Closer. A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

News | Cardiovascular Surgery | December 11, 2018

December 11, 2018 — The scientific journal...

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.

Feature | Heart Failure | October 19, 2018

October 19, 2018 — Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U....

Abiomed Showcases Expanded FDA Indications, Next-Generation Heart Recovery Products at TCT 2018
News | Hemodynamic Support Devices | September 20, 2018

September 19, 2018 — Abiomed Inc. announces its initiatives at the 30th Transcatheter Cardiovascular Therapeutics (...

Sponsored Content | Videos | Cath Lab | September 19, 2018

William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ)...

Videos | Hemodynamic Support Devices | August 31, 2018

Behnam Tehrani, M.D., FSCAI, director of the cardiac cath lab, INOVA Heart and Vascular Institute, Fairfax, Va.,...

Overlay Init